Vergoeding 2019-2023 voor ATC-subgroep R03BB : Parasympathicolytica
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| R03BB01 Ipratropium (Atrovent ®) | 3.067.900 | 2.922.600 | 2.642.800 | 2.538.100 | 2.364.000 |
| R03BB04 Tiotropium (Spiriva ®) | 59.435.700 | 55.215.300 | 39.116.300 | 33.726.100 | 29.766.300 |
| R03BB05 Aclidiniumbromide (Eklira ®) | 1.253.500 | 1.191.500 | 1.099.600 | 1.058.700 | 1.039.500 |
| R03BB06 Glycopyrroniumbromide (Seebri breezhaler ®) | 1.821.800 | 1.574.100 | 1.219.700 | 1.125.200 | 959.540 |
| R03BB07 Umeclidiniumbromide (Incruse ellipta ®) | 689.650 | 774.360 | 1.963.200 | 2.001.200 | 1.967.600 |
| Totaal | 66.268.550 | 61.677.860 | 46.041.600 | 40.449.300 | 36.096.940 |